These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 38200039)
21. Quercetin induces MGMT Wang W; Yuan X; Mu J; Zou Y; Xu L; Chen J; Zhu X; Li B; Zeng Z; Wu X; Yin Z; Wang Q Phytomedicine; 2023 Sep; 118():154933. PubMed ID: 37451151 [TBL] [Abstract][Full Text] [Related]
22. POLR3G promotes EMT via PI3K/AKT signaling pathway in bladder cancer. Chen H; Ma L; Yang W; Li Y; Ji Z FASEB J; 2023 Dec; 37(12):e23260. PubMed ID: 37933949 [TBL] [Abstract][Full Text] [Related]
23. Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification. Shu W; Wang Z; Zhao R; Shi R; Zhang J; Zhang W; Wang H Drug Des Devel Ther; 2022; 16():1847-1863. PubMed ID: 35734366 [TBL] [Abstract][Full Text] [Related]
24. Berberine Affects the Proliferation, Migration, Invasion, Cell Cycle, and Apoptosis of Bladder Cancer Cells T24 and 5637 by Down-Regulating the HER2/PI3K/AKT Signaling Pathway. Li Q; Qing L; Xu W; Yang Y; You C; Lao Y; Dong Z Arch Esp Urol; 2023 Mar; 76(2):152-160. PubMed ID: 37139621 [TBL] [Abstract][Full Text] [Related]
25. Apatinib Inhibits Bladder Cancer through Suppression of the VEGFR2- PI3K-AKT Signaling Pathway as Revealed by Network Pharmacology and Wang W; Chen L; Yang J; Hu D; Yang Y; Dong T; Long X; Zou Y; Li J; Ma X; Dai W; Zhou X; Chen B; Su Y Comb Chem High Throughput Screen; 2023; 26(13):2380-2392. PubMed ID: 36852790 [TBL] [Abstract][Full Text] [Related]
26. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation. Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B Front Immunol; 2023; 14():1235575. PubMed ID: 37799727 [TBL] [Abstract][Full Text] [Related]
27. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke. Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367 [TBL] [Abstract][Full Text] [Related]
28. The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway. Li M; Zhang W; Yang L; Wang H; Wang Y; Huang K; Zhang W Dis Markers; 2021; 2021():4304507. PubMed ID: 34306252 [TBL] [Abstract][Full Text] [Related]
29. Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K/Akt and mitochondrial-associated apoptotic pathway. Han B; Jiang P; Li Z; Yu Y; Huang T; Ye X; Li X Phytomedicine; 2018 Sep; 48():152-160. PubMed ID: 30195873 [TBL] [Abstract][Full Text] [Related]
30. Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway. Shen Z; Xue D; Wang K; Zhang F; Shi J; Jia B; Yang D; Zhang Q; Zhang S; Jiang H; Luo D; Li X; Zhong Q; Zhang J; Peng Z; Han Y; Sima C; He X; Hao L BMC Urol; 2022 May; 22(1):79. PubMed ID: 35610639 [TBL] [Abstract][Full Text] [Related]
31. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification. Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740 [TBL] [Abstract][Full Text] [Related]
32. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation. Wang YC; Hui JR; Xiao G; Ma QL Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117 [TBL] [Abstract][Full Text] [Related]
33. Salidroside intensifies mitochondrial function of CoCl Hou Y; Zhang Y; Jiang S; Xie N; Zhang Y; Meng X; Wang X Phytomedicine; 2023 Jan; 109():154568. PubMed ID: 36610162 [TBL] [Abstract][Full Text] [Related]
34. [Mechanism of Zhongfeng Xingnao Decoction in improving microcirculatory disorders in cerebral hemorrhage based on network pharmacology and molecular docking techniques]. Zhong XQ; Hu DF; Wang Y; Ning ZQ; Deng MZ Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6115-6127. PubMed ID: 38114219 [TBL] [Abstract][Full Text] [Related]
35. Network-based Pharmacology and Long X; Chen L; Yang J; Dong T; Cheng Q; Wang W; Zou Y; Su Y; Dai W; Chen B; Zhou X Anticancer Agents Med Chem; 2023; 23(7):847-857. PubMed ID: 36305128 [TBL] [Abstract][Full Text] [Related]
36. 6-Methoxydihydrosanguinarine induces apoptosis and autophagy in breast cancer MCF-7 cells by accumulating ROS to suppress the PI3K/AKT/mTOR signaling pathway. Zhang L; Zhang X; Che D; Zeng L; Zhang Y; Nan K; Zhang X; Zhang H; Guo Z Phytother Res; 2023 Jan; 37(1):124-139. PubMed ID: 36116140 [TBL] [Abstract][Full Text] [Related]
37. Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage Polarization and Bladder Cancer Cells Growth. Wu P; Zhao L; Kong G; Song B Technol Cancer Res Treat; 2024; 23():15330338241246649. PubMed ID: 38656249 [No Abstract] [Full Text] [Related]
38. Flaccidoxide-13-Acetate-Induced Apoptosis in Human Bladder Cancer Cells is through Activation of p38/JNK, Mitochondrial Dysfunction, and Endoplasmic Reticulum Stress Regulated Pathway. Wu YJ; Su TR; Dai GF; Su JH; Liu CI Mar Drugs; 2019 May; 17(5):. PubMed ID: 31086026 [TBL] [Abstract][Full Text] [Related]
39. Antitumor effects of flavokawain-B flavonoid in gemcitabine-resistant lung cancer cells are mediated via mitochondrial-mediated apoptosis, ROS production, cell migration and cell invasion inhibition and blocking of PI3K/AKT Signaling pathway. Hua R; Pei Y; Gu H; Sun Y; He Y J BUON; 2020; 25(1):262-267. PubMed ID: 32277640 [TBL] [Abstract][Full Text] [Related]
40. SYNPO2 promotes the development of BLCA by upregulating the infiltration of resting mast cells and increasing the resistance to immunotherapy. Ye G; Tu L; Li Z; Li X; Zheng X; Song Y Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 38038167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]